PRESS RELEASE published on 02/16/2026 at 10:14, 2 months 22 days ago Viromed Medical AG: Globally unique preclinical data base – Saarland validation as key step toward first physical lung application Viromed Medical AG presents globally unique preclinical data on cold plasma therapy for lung infections, with Saarland validation confirming a key step towards clinical application Preclinical Data Viromed Medical AG Cold Plasma Therapy Lung Infections Saarland Validation
BRIEF published on 01/27/2026 at 16:48, 3 months 14 days ago MHH dévoilera ses recherches sur la thérapie par plasma froid pour les applications pulmonaires. Innovation Médicale Résistance Aux Antibiotiques Viromed Medical AG Thérapie Par Plasma Froid Infections Pulmonaires
BRIEF published on 01/27/2026 at 16:48, 3 months 14 days ago MHH to Unveil Cold Plasma Therapy Research for Lung Applications Medical Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Therapy Lung Infections
PRESS RELEASE published on 01/27/2026 at 16:43, 3 months 14 days ago MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026 MHH to present groundbreaking cold plasma therapy for pulmonary application at press conference in February 2026, addressing urgent clinical need worldwide Scientific Findings Press Conference Viromed Medical AG Cold Plasma Therapy Pulmonary Application
BRIEF published on 01/19/2026 at 13:01, 3 months 22 days ago Viromed Medical AG franchit une étape importante avec une étude pulmonaire ex vivo Recherche Médicale Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Progrès Pharmaceutique
BRIEF published on 01/19/2026 at 13:01, 3 months 22 days ago Viromed Medical AG Achieves Milestone with Ex-Vivo Lung Study Medical Research Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Pharmaceutical Advancement
PRESS RELEASE published on 01/19/2026 at 12:56, 3 months 22 days ago Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG to conduct ex-vivo lung study on vital lungs in cooperation with universities for accelerated research and approval processes Medical Technology Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Research Milestone
BRIEF published on 01/19/2026 at 11:50, 3 months 22 days ago Viromed Medical AG Advances with Ex-Vivo Lung Study Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Preclinical Research Acceleration Saarland University Collaboration
BRIEF published on 01/19/2026 at 11:50, 3 months 22 days ago Viromed Medical AG fait progresser son étude pulmonaire ex vivo Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Accélération De La Recherche Préclinique Collaboration De L'Université De La Sarre
PRESS RELEASE published on 01/19/2026 at 11:45, 3 months 22 days ago Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG's ex-vivo lung study with Saarland University and MHH is a significant milestone for research & approval, accelerating development processes Research Approval Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study
Published on 05/09/2026 at 01:30, 1 day 23 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 1 hour ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 9 hours 1 minute ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 11 hours 6 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 13 hours 21 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 6 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 4 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 5 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 5 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
